![Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation - ScienceDirect Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821005596-fx1.jpg)
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation - ScienceDirect
![RCSB PDB - 7O7Y: Rabbit 80S ribosome stalled close to the mutated SARS-CoV-2 slippery site by a pseudoknot (high resolution) RCSB PDB - 7O7Y: Rabbit 80S ribosome stalled close to the mutated SARS-CoV-2 slippery site by a pseudoknot (high resolution)](https://cdn.rcsb.org/images/structures/o7/7o7y/7o7y_chain-R.jpeg)
RCSB PDB - 7O7Y: Rabbit 80S ribosome stalled close to the mutated SARS-CoV-2 slippery site by a pseudoknot (high resolution)
![Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation - ScienceDirect Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821005596-gr8.jpg)
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation - ScienceDirect
![PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice | EMBO reports PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice | EMBO reports](https://www.embopress.org/cms/asset/1a30cde8-3367-4db2-8eb8-43d81e08b833/embr202153007-fig-0002ev-m.jpg)